Literature DB >> 12817953

Electronic structure of oxovanadium IV complexes of alpha-hydroxycarboxylic acids.

Eugenio Garribba1, Giovanni Micera, Angelo Panzanelli, Daniele Sanna.   

Abstract

A series of V(IV)O bis chelated complexes of alpha-hydroxycarboxylic acids with a 2(COO(-), O(-)) coordination set was analyzed by electronic absorption and EPR spectroscopy in aqueous solution. All the complexes exhibit a square-pyramidal geometry distorted toward trigonal bipyramid. The influence of the distortion of the geometry, as deduced from the steric hindrance produced by the substituents at the alpha-carbon atom of the ligands, on the spectroscopic parameters has been studied. The observed trends were related to the electronic structure of the metal ion in the distorted geometry.

Entities:  

Year:  2003        PMID: 12817953     DOI: 10.1021/ic0260567

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  4 in total

1.  Synthesis, characterization, antitumoral and osteogenic activities of quercetin vanadyl(IV) complexes.

Authors:  Evelina G Ferrer; María V Salinas; María J Correa; Luciana Naso; Daniel A Barrio; Susana B Etcheverry; Luis Lezama; Teófilo Rojo; Patricia A M Williams
Journal:  J Biol Inorg Chem       Date:  2006-07-05       Impact factor: 3.358

2.  A quantitative study of the biotransformation of insulin-enhancing VO(2+) compounds.

Authors:  Daniele Sanna; Péter Buglyó; Giovanni Micera; Eugenio Garribba
Journal:  J Biol Inorg Chem       Date:  2010-03-26       Impact factor: 3.358

3.  Decreasing the diabetic complication by vanadyl(VO)2+/vitamin B 6 complex in alloxan-induced diabetic mice.

Authors:  Nahla S El-Shenawy; Moamen S Refat; Fatima H Fakihi
Journal:  J Mater Sci Mater Med       Date:  2013-02-09       Impact factor: 3.896

4.  Synthesis and Characterization of Oxidovanadium(IV) Complexes of 2-((E)-(6-Fluorobenzo[d]thiazol-2-ylimino)methyl)-6-methoxyphenol and Their Antimicrobial, Antioxidant, and DNA-Binding Studies.

Authors:  K Savithri; H D Revanasiddappa
Journal:  Bioinorg Chem Appl       Date:  2018-06-27       Impact factor: 7.778

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.